Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $40.9100 (-10.83%) ($40.9100 - $40.9100) on Wed. Mar. 24, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.66% (three month average) | RSI | 56 | Latest Price | $40.9100(-10.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.4% a day on average for past five trading days. | Weekly Trend | EDIT advances 1.5% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(59%) IBUY(58%) IPO(56%) | Factors Impacting EDIT price | EDIT will decline at least -2.83% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-7%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.83% (StdDev 5.66%) | Hourly BBV | -2.2 () | Intraday Trend | 0% | | | |
|
Resistance Level | $44.83 | 5 Day Moving Average | $44.7(-8.48%) | 10 Day Moving Average | $45.61(-10.3%) | 20 Day Moving Average | $44.83(-8.74%) | To recent high | -55% | To recent low | 1.8% | Market Cap | $2.541b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |